William Lis
2018 - Portola Pharmaceuticals
In 2018, William Lis earned a total compensation of $5.3M as Former Chief Executive Officer at Portola Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $290,200 |
|---|---|
| Option Awards | $2,976,440 |
| Salary | $420,717 |
| Stock Awards | $1,282,750 |
| Other | $296,199 |
| Total | $5,266,306 |
Lis received $3M in option awards, accounting for 57% of the total pay in 2018.
Lis also received $290.2K in non-equity incentive plan, $420.7K in salary, $1.3M in stock awards and $296.2K in other compensation.
Rankings
In 2018, William Lis' compensation ranked 1,882nd out of 14,244 executives tracked by ExecPay. In other words, Lis earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,882 out of 14,244 | 87th |
Division Manufacturing | 674 out of 5,758 | 88th |
Major group Chemicals And Allied Products | 220 out of 2,119 | 90th |
Industry group Drugs | 173 out of 1,808 | 90th |
Industry Pharmaceutical Preparations | 131 out of 1,382 | 91st |
Source: SEC filing on April 19, 2019.
Lis' colleagues
We found six more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2018.
2018
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
2018
John Moriarty
Portola Pharmaceuticals
General Counsel
2018
Glenn Brame
Portola Pharmaceuticals
Executive Vice President, Chief Technical Operations Officer
2018
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
2018
Mardi Dier
Portola Pharmaceuticals
Executive Vice President, Chief Financial and Business Officer
2018
John Curnutte
Portola Pharmaceuticals